Share Name Share Symbol Market Type Share ISIN Share Description
Worldwide Hc LSE:WWH London Ordinary Share GB0003385308 ORD 25P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -5.00p -0.24% 2,119.00p 2,118.00p 2,126.00p 2,130.00p 2,117.00p 2,122.00p 49,567 16:27:09
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Equity Investment Instruments 0.0 9.3 17.1 123.9 985.93

Worldwide (WWH) Latest News (4)

More Worldwide News
Worldwide Takeover Rumours

Worldwide (WWH) Share Charts

1 Year Worldwide Chart

1 Year Worldwide Chart

1 Month Worldwide Chart

1 Month Worldwide Chart

Intraday Worldwide Chart

Intraday Worldwide Chart

Worldwide (WWH) Discussions and Chat

Worldwide Forums and Chat

Date Time Title Posts
18/5/201612:25Worldwide Healthcare Trust PLC42
26/9/199918:20Woolwich buying own shares-
26/9/199918:13woolwich buying its own shares-

Add a New Thread

Worldwide (WWH) Most Recent Trades

No Trades
Trade Time Trade Price Trade Size Trade Value Trade Type
View all Worldwide trades in real-time

Worldwide (WWH) Top Chat Posts

Worldwide Daily Update: Worldwide Hc is listed in the Equity Investment Instruments sector of the London Stock Exchange with ticker WWH. The last closing price for Worldwide was 2,124p.
Worldwide Hc has a 4 week average price of 2,141.95p and a 12 week average price of 2,106.15p.
The 1 year high share price is 2,208p while the 1 year low share price is currently 1,548p.
There are currently 46,528,088 shares in issue and the average daily traded volume is 52,661 shares. The market capitalisation of Worldwide Hc is £985,930,184.72.
strollingmolby: Results to 31-Mar-13 out: REVIEW OF THE YEAR AND PERFORMANCE I am delighted to report that during the year ended 31 March 2013, the Company's net asset value per share total return was 30.3% and the share price total return was 30.9%, both closely tracking the Company's benchmark, the MSCI World Health Care Index on a net total return, sterling adjusted basis, which rose by 31.4%. I should point out that the share price and the net asset value total return generated during the year were enhanced by the change in the Company's dividend payment policy whereby a first interim dividend of 7.0p per share was paid in January 2013. This "extra" dividend payment enhanced performance in total return terms by approximately 1.0%. The Company has continued to benefit from strong performance from biopharmaceutical companies such as Gilead Sciences and Onyx Pharmaceuticals, and also from large capitalisation pharmaceutical companies such as Roche Holdings, Pfizer and Sanofi. Further information on the Company's investments can be found in the Review of Investments beginning on page 5 of this Annual Report.
Worldwide share price data is direct from the London Stock Exchange
Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:42 V: D:20161023 16:10:43